A highly prevalent equine glycogen storage disease is explained by constitutive activation of a mutant glycogen synthase

C. A. Maile, J. R. Hingst, K. K. Mahalingan, A. O. O'Reilly, M. E. Cleasby, J. R. Mickelson, M. E. McCue, S. M. Anderson, T. D. Hurley, J. F.P. Wojtaszewski, R. J. Piercy

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

Background Equine type 1 polysaccharide storage myopathy (PSSM1) is associated with a missense mutation (R309H) in the glycogen synthase (GYS1) gene, enhanced glycogen synthase (GS) activity and excessive glycogen and amylopectate inclusions in muscle. Methods Equine muscle biochemical and recombinant enzyme kinetic assays in vitro and homology modelling in silico, were used to investigate the hypothesis that higher GS activity in affected horse muscle is caused by higher GS expression, dysregulation, or constitutive activation via a conformational change. Results PSSM1-affected horse muscle had significantly higher glycogen content than control horse muscle despite no difference in GS expression. GS activity was significantly higher in muscle from homozygous mutants than from heterozygote and control horses, in the absence and presence of the allosteric regulator, glucose 6 phosphate (G6P). Muscle from homozygous mutant horses also had significantly increased GS phosphorylation at sites 2 + 2a and significantly higher AMPKα1 (an upstream kinase) expression than controls, likely reflecting a physiological attempt to reduce GS enzyme activity. Recombinant mutant GS was highly active with a considerably lower Km for UDP-glucose, in the presence and absence of G6P, when compared to wild type GS, and despite its phosphorylation. Conclusions Elevated activity of the mutant enzyme is associated with ineffective regulation via phosphorylation rendering it constitutively active. Modelling suggested that the mutation disrupts a salt bridge that normally stabilises the basal state, shifting the equilibrium to the enzyme's active state. General significance This study explains the gain of function pathogenesis in this highly prevalent polyglucosan myopathy.

Original languageEnglish (US)
Pages (from-to)3388-3398
Number of pages11
JournalBiochimica et Biophysica Acta - General Subjects
Volume1861
Issue number1
DOIs
StatePublished - Jan 1 2017

Keywords

  • Glycogen
  • Glycogen storage disease
  • Glycogen synthase
  • Muscle
  • PSSM1
  • Polyglucosan

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology

Fingerprint Dive into the research topics of 'A highly prevalent equine glycogen storage disease is explained by constitutive activation of a mutant glycogen synthase'. Together they form a unique fingerprint.

  • Cite this

    Maile, C. A., Hingst, J. R., Mahalingan, K. K., O'Reilly, A. O., Cleasby, M. E., Mickelson, J. R., McCue, M. E., Anderson, S. M., Hurley, T. D., Wojtaszewski, J. F. P., & Piercy, R. J. (2017). A highly prevalent equine glycogen storage disease is explained by constitutive activation of a mutant glycogen synthase. Biochimica et Biophysica Acta - General Subjects, 1861(1), 3388-3398. https://doi.org/10.1016/j.bbagen.2016.08.021